TOP

September Teal Feed, The Gynecologic Cancer Awareness Month

Date: 2019-09-04
Views: 409

September Teal Feed, The Gynecologic Cancer Awareness Month

The calendar turns to the color Teal in September that ties with the Gynecologic Cancer Awareness Month to spread the words of gynecologic cancers education. Gynecological cancers refer to cancers start in women reproductive organ. In America, every six minutes a woman is diagnosed with gynecological cancer and the threat of this health issue is not limited to women in the US but women across the globe.

 

To tackle this gynecological health issue, it’s important to offer the public vital information on risk cancers and their correlative symptoms and prevention strategies. Overall, there are five types of gynecological, namely ovarian, uterine, cervical, vaginal and vulvar cancers.


Ovarian Cancer

While ovarian cancer accounts for about 3% of cancers among women, it causes more deaths than other gynecological cancers. Because there is no recommended routine screening for women without ovarian cancer symptoms and symptoms will not show until it was too late, thus ovarian cancer is also named ‘the silent killer’ that ranks fourth in cancer deaths among women.

Correlative Symptoms

Prevention Strategies

l  Extreme, sudden onset bloating

l  Pelvic or abdominal pain

l  Difficulty eating or feeling full quickly

l  Urinary symptoms (urgency or frequency)

l  Rectovaginal pelvic exam,

l  Transvaginal ultrasound

l  CA125 blood test.

(See below Fapon CA125 Performance)


Uterine CancerEndometrial Cancer

Uterine cancer is the most common type of other gynecological cancers. Women who have gone through menopause have a greater chance of developing uterine cancer and other risks factor include being age 50 or older, obesity, higher circulating levels of estrogen and having a family history of uterine, ovarian or colon cancer. There is also no routine testing is recommended for uterine cancer and hence it’s important to aware all symptoms.

Correlative Symptoms

Prevention Strategies

l  Vaginal bleeding or spotting after menopause

l  New onset of heavy menstrual periods or bleeding between periods

l  A watery pink or white discharge from the vagina

l  Two or more weeks of persistent pain in the lower abdomen or pelvic area

l  Pain during sexual intercourse

l  Transvaginal ultrasound

l  Uterus lining examination

(hysteroscopy)

l  Tissue sampling (biopsy)


Cervical Cancer

Despite cervical cancer ranks the second common cause of death in gynecological cancers, luckily most women with an HPV infection will not develop cervical cancer. And especially note to cervical cancer is that early detection and treatments of abnormal cells are available to prevent cancer development. However cervical cancer typically doesn’t have any symptoms in the early stage and thus a preventive vaccination and regular screenings are extremely important.

Correlative Symptoms

Prevention Strategies

l  Vaginal discharge

l  Abnormal vaginal bleeding

l  Vaginal odor

l  Bleeding following sexual intercourse

l  Pain

l  HPV vaccination

l  Routine Pap tests to screen for HPV or sign


Vaginal & Vulvar Cancer

Vaginal and vulvar cancer are both rarely diagnosed gynecologic cancers and typically affecting elderly women. Like cervical cancer, vaginal and vulvar cancers are also associated with HPV infection, therefore vaccinating women and young girls before they are sexually active is crucial. However vaginal and vulvar cancers are different in terms of symptoms, understanding these warnings signs will greatly improve chances of early detection.

Cancer

Symptoms

Prevention Strategies

Vaginal

l  Abnormal vaginal bleeding

l  Abnormal vaginal discharge

l  An obvious mass

l  Pain during intercourse

l  HPV vaccination

l  pelvic examinations

Vulvar

l  A red, pink or white bump that has a raw or wart-like surface

l  A white area that feels rough

l  Persistent itching

l  Pain, or a burning feeling while urinating

l  Bleeding and discharge not associated with menstruation


Fapon IVD Reagent Raw Materials for Ovarian Cancer 


CA125

The antigenic determinant of CA125 is associated with a large molecular weight glycoprotein of the ovarian cavity epithelium during embryonic development. CA125 can be used to detect common non-mucinous epithelial ovarian cancers, but it may not be helpful in the detection of endometrial carcinoma and clear cell carcinoma.

Recommended

Pairs

Catalog No.

Recommended Usage

Application Platform

BECCA125S105

Coating

ELISA/CLIA

BENCA125S101

Labeling

September Teal Feed, The Gynecologic Cancer Awareness Month


HE4

Studies have found that HE4 sensitivity to early ovarian cancer can reach as high as 45.9% at 95% specificity compared with benign diseases. HE4 levels decrease after ovarian cancer surgery and increase as early as 30 weeks before clinical recurrence. HE4 levels are highly associated with disease progression in ovarian cancer patients. Therefore, HE4 serves as an important indicator for the post-operative follow-ups on ovarian malignant tumors as well as a sensitive indicator for the monitoring of early recurrence.

Recommended

Pairs

Catalog No.

Recommended Usage

Application Platform

BECHE4S102

Coating

ELISA/CLIA

BEJHE4S102

Labeling

September Teal Feed, The Gynecologic Cancer Awareness Month

  form>